share_log

JMP Securities Reiterates Market Outperform on Cellectis, Maintains $6 Price Target

Benzinga ·  Nov 1, 2023 12:58

JMP Securities analyst Silvan Tuerkcan reiterates Cellectis (NASDAQ:CLLS) with a Market Outperform and maintains $6 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment